NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action. Investors have until July 22, 2025, to ask the Court to be appointed to lea ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Organon investors who were adversely affected by alleged securities fraud between October 31, 2024 and April 30, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/organon-co-lawsuit-submission-for ...

LOS ANGELES, June 13, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ORGANON INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YO ...

LOS ANGELES, June 13, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws.Shareholders who purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 22, 2025.     CASE DETAILS:  The complaint alleges that the Company made false and misleading statements to the market con ...

NEW YORK, June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Organon investors who were adversely affected by alleged securities fraud between October 31, 2024 and April 30, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid ...

法律调查与投资者诉讼 - 律师事务所Faruqi & Faruqi正在调查Organon & Co潜在证券索赔案件 并提醒投资者在2025年7月22日前申请成为集体诉讼的首席原告 [3] - 调查涉及Organon在2024年10月31日至2025年4月30日期间可能存在的证券欺诈行为 鼓励受影响投资者联系律所 [1][3] - 律所在证券诉讼领域有丰富经验 自1995年成立以来已为投资者追回数亿美元损失 [4] 公司信息披露问题 - Organon管理层被指控在资本分配策略上发布误导性声明 强调季度分红是"第一优先级" 但隐瞒了债务削减计划的实际优先级 [5] - 公司收购Dermavant后 季度分红骤降70% 但未及时披露债务重组对分红政策的实质性影响 [5] - 这些信息缺失导致投资者以虚高价格买入公司证券 [5] 市场反应 - 2025年4月30日至5月1日期间 Organon股价从每股12 93美元暴跌至9 45美元 单日跌幅超过27% [6] - 股价剧烈波动直接源于公司资本分配策略真相的披露 [5][6] 诉讼程序 - 法院将指定财务利益最大的适格投资者作为首席原告 代表集体诉讼成员主导诉讼进程 [7] - 投资者可选择主动担任首席原告或保持缺席成员身份 均不影响最终赔偿权益 [8] - 律所同时征集知情人士提供线索 包括举报人、前员工和股东等 [8]

公司动态 - Organon & Co (NYSE: OGN) 股东在2024年10月31日至2025年4月30日期间购入股票者可能成为集体诉讼的潜在原告 [3] - 公司被指控在资本分配和季度股息方面向投资者发布虚假或误导性陈述 同时隐瞒债务削减策略的高优先级 [3] - 公司在收购Dermavant后大幅削减季度股息70% 导致股价在2025年5月1日单日暴跌27% 从4月30日收盘价12.93美元跌至9.45美元 [3] 法律程序 - 股东参与集体诉讼的截止日期为2025年7月22日 注册后可获得案件进展监控服务 [4] - Gross Law Firm作为全国知名集体诉讼律所 专注于因公司虚假陈述导致投资损失的案件代理 [5]

SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon and certain of Organon’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Organon class action lawsuit, please provide your ...

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action. Investors have until July 22, 2025, to ask the Court to be appointed to lea ...

NEW YORK, June 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=152579&from=4CLASS PERIOD: October 31, 2024 to April 30, 20 ...